Global Oncology Drugs Competitive Landscape Professional Research Report 2024

Research Summary

Oncology drugs, also known as anticancer or cancer drugs, are medications specifically designed to treat various types of cancer. These drugs work by targeting and inhibiting the growth of cancer cells, preventing their ability to proliferate and spread throughout the body. There are several classes of oncology drugs, including chemotherapy agents, targeted therapies, immunotherapies, hormone therapies, and others. Chemotherapy drugs are cytotoxic and can kill rapidly dividing cancer cells, but they may also affect healthy cells in the body. Targeted therapies focus on specific molecular targets that are involved in cancer cell growth and survival, minimizing damage to healthy cells. Immunotherapies use the body's immune system to recognize and attack cancer cells. Hormone therapies interfere with the hormones that fuel the growth of certain cancers. Oncology drugs can be administered orally, intravenously, or through other routes, and they are typically prescribed by oncologists based on the specific type and stage of cancer, as well as individual patient characteristics. The field of oncology continues to see advancements in drug development, leading to increasingly personalized and effective treatments for cancer patients.

According to DIResearch's in-depth investigation and research, the global Oncology Drugs market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Oncology Drugs include Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer, Amgen, Eli Lilly, AbbVie, Takeda, Astellas, Ipsen etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Oncology Drugs. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Oncology Drugs market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Oncology Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oncology Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Oncology Drugs Include:

Roche

Celgene

Novartis

Bristol-Myers Squibb

Johnson & Johnson

Merck & Co.

AstraZeneca

Pfizer

Amgen

Eli Lilly

AbbVie

Takeda

Astellas

Ipsen

Oncology Drugs Product Segment Include:

Chemotherapy

Targeted Therapy

Immunotherapy (Biologic Therapy)

Hormonal Therapy

Others

Oncology Drugs Product Application Include:

Blood Cancer

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Respiratory or Lung Cancer

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Oncology Drugs Industry PESTEL Analysis

Chapter 3: Global Oncology Drugs Industry Porter's Five Forces Analysis

Chapter 4: Global Oncology Drugs Major Regional Market Size and Forecast Analysis

Chapter 5: Global Oncology Drugs Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Oncology Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Oncology Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Oncology Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Oncology Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Oncology Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Oncology Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Oncology Drugs Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Oncology Drugs Market Overview

1.1 Product Definition and Statistical Scope

1.2 Oncology Drugs Product by Type

1.2.1 Global Oncology Drugs Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Chemotherapy

1.2.3 Targeted Therapy

1.2.4 Immunotherapy (Biologic Therapy)

1.2.5 Hormonal Therapy

1.2.6 Others

1.3 Oncology Drugs Product by Application

1.3.1 Global Oncology Drugs Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Blood Cancer

1.3.3 Breast Cancer

1.3.4 Gastrointestinal Cancer

1.3.5 Prostate Cancer

1.3.6 Respiratory or Lung Cancer

1.3.7 Others

1.4 Global Oncology Drugs Market Revenue Analysis (2019-2030)

1.5 Oncology Drugs Market Development Status and Trends

1.5.1 Oncology Drugs Industry Development Status Analysis

1.5.2 Oncology Drugs Industry Development Trends Analysis

2 Oncology Drugs Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Oncology Drugs Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Oncology Drugs Market Analysis by Regions

4.1 Oncology Drugs Overall Market: 2023 VS 2024 VS 2030

4.2 Global Oncology Drugs Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Oncology Drugs Revenue and Market Share by Region (2019-2024)

4.2.2 Global Oncology Drugs Revenue Forecast by Region (2025-2030)

5 Global Oncology Drugs Market Size by Type and Application

5.1 Global Oncology Drugs Market Size by Type

5.2 Global Oncology Drugs Market Size by Application

6 North America

6.1 North America Oncology Drugs Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Oncology Drugs Market Size by Type

6.4 North America Oncology Drugs Market Size by Application

6.5 North America Oncology Drugs Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Oncology Drugs Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Oncology Drugs Market Size by Type

7.4 Europe Oncology Drugs Market Size by Application

7.5 Europe Oncology Drugs Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Oncology Drugs Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Oncology Drugs Market Size by Type

8.4 China Oncology Drugs Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Oncology Drugs Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Oncology Drugs Market Size by Type

9.4 APAC (excl. China) Oncology Drugs Market Size by Application

9.5 APAC (excl. China) Oncology Drugs Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Oncology Drugs Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Oncology Drugs Market Size by Type

10.4 Latin America Oncology Drugs Market Size by Application

10.5 Latin America Oncology Drugs Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Oncology Drugs Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Oncology Drugs Market Size by Type

11.4 Middle East & Africa Oncology Drugs Market Size by Application

11.5 Middle East & Africa Oncology Drugs Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Oncology Drugs Market Revenue by Key Manufacturers (2020-2024)

12.2 Oncology Drugs Competitive Landscape Analysis and Market Dynamic

12.2.1 Oncology Drugs Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Roche

13.1.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Roche Oncology Drugs Product Portfolio

13.1.3 Roche Oncology Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Celgene

13.2.1 Celgene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Celgene Oncology Drugs Product Portfolio

13.2.3 Celgene Oncology Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Novartis

13.3.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Novartis Oncology Drugs Product Portfolio

13.3.3 Novartis Oncology Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Bristol-Myers Squibb

13.4.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Bristol-Myers Squibb Oncology Drugs Product Portfolio

13.4.3 Bristol-Myers Squibb Oncology Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Johnson & Johnson

13.5.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Johnson & Johnson Oncology Drugs Product Portfolio

13.5.3 Johnson & Johnson Oncology Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Merck & Co.

13.6.1 Merck & Co. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Merck & Co. Oncology Drugs Product Portfolio

13.6.3 Merck & Co. Oncology Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 AstraZeneca

13.7.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 AstraZeneca Oncology Drugs Product Portfolio

13.7.3 AstraZeneca Oncology Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Pfizer

13.8.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Pfizer Oncology Drugs Product Portfolio

13.8.3 Pfizer Oncology Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Amgen

13.9.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Amgen Oncology Drugs Product Portfolio

13.9.3 Amgen Oncology Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Eli Lilly

13.10.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Eli Lilly Oncology Drugs Product Portfolio

13.10.3 Eli Lilly Oncology Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 AbbVie

13.11.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 AbbVie Oncology Drugs Product Portfolio

13.11.3 AbbVie Oncology Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Takeda

13.12.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Takeda Oncology Drugs Product Portfolio

13.12.3 Takeda Oncology Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Astellas

13.13.1 Astellas Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Astellas Oncology Drugs Product Portfolio

13.13.3 Astellas Oncology Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Ipsen

13.14.1 Ipsen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Ipsen Oncology Drugs Product Portfolio

13.14.3 Ipsen Oncology Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Oncology Drugs Industry Chain Analysis

14.2 Oncology Drugs Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Oncology Drugs Typical Downstream Customers

14.4 Oncology Drugs Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support